We are a Data Science Company for
“Reinventing Clinical Trial Data with
Digital Health Technologies”.
News
admin2022-11-02T15:31:14+09:00November 1st, 2022|
Publications
CDISC-compliant clinical trial imaging management system with automatic verification and data Transformation: Focusing on tumor response assessment data in clinical trials
Original Research Authors: Amy Junghyun Lee, Kyung Won Kim, Youngbin Shin, Jiwoo Lee, Hyo Jung Park, Young Chul Cho, Yousun Ko, Yu Sub Sung, Byung Sun Yoon, J Biomed Inform. 2021 Apr 9 Objective: Major issues in imaging data management of tumor response
Investor Relations
Newsletter no.4 October 2022
Dana-Farber Cancer Institue Interim Chair, Dr. Atul B. Shinagare의 방문 Atul B. Shinagare, MD (Interim Chair, Department of Imaging Center, Dana-Farber Cancer Institue & Associate Professor of Radiology, Harvard Medical School )가 지난 9월 21일 TI를 방문했습니다. Dr.Atul은 TI의 클라우드 기반의 다학제 종양